Yuriko Mori
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Surgery
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Frederik L. GieselJens CardinaleUwe HaberkornClemens KratochwilAkira HoriiMasami SatoAkira SakuradaKatharina Dendl
- Topics
- Peptidase Inhibition and Analysis (22 papers)Cardiac Structural Anomalies and Repair (12 papers)Protease and Inhibitor Mechanisms (12 papers)
- Journals
- The Journal of Experimental MedicineSHILAP Revista de lepidopterologíaCancer
- Partner nations
- GermanyJapanUnited States
In The Last Decade
Yuriko Mori
35 papers receiving 760 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 355
- Molecular Biology 265
- Cancer Research 195
- Surgery 177
- Radiology, Nuclear Medicine and Imaging 118
Countries citing papers authored by Yuriko Mori
This map shows the geographic impact of Yuriko Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuriko Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuriko Mori more than expected).
Fields of papers citing papers by Yuriko Mori
This network shows the impact of papers produced by Yuriko Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuriko Mori. The network helps show where Yuriko Mori may publish in the future.
Co-authorship network of co-authors of Yuriko Mori
This figure shows the co-authorship network connecting the top 25 collaborators of Yuriko Mori. A scholar is included among the top collaborators of Yuriko Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuriko Mori. Yuriko Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | 21 | |
| 9 | 2 | |
| 10 | FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Diseasebreakdown → | 177 |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 25 | |
| 16 | 11 | |
| 17 | 17 | |
| 18 | 0 | |
| 19 | 2 | |
| 20 | 68 |
About Yuriko Mori
Yuriko Mori is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 775 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (22 papers), Cardiac Structural Anomalies and Repair (12 papers) and Protease and Inhibitor Mechanisms (12 papers). The work is most often cited by research in Oncology (355 citations), Cancer Research (195 citations) and Radiology, Nuclear Medicine and Imaging (118 citations). Yuriko Mori has collaborated with scholars based in Germany, Japan and United States. Frequent co-authors include Frederik L. Giesel, Jens Cardinale, Uwe Haberkorn, Clemens Kratochwil, Akira Horii, Masami Sato, Akira Sakurada, Katharina Dendl, Toshihiro Nukiwa and Takuji Suzuki. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.